tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Patrys Limited Announces Director Departure

Story Highlights
  • Patrys Limited operates in the biotechnology industry, focusing on antibody therapies.
  • James Campbell’s departure as director may impact Patrys’ strategic direction and stakeholder confidence.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Patrys Limited Announces Director Departure

Meet Your ETF AI Analyst

Patrys Limited ( (AU:PAB) ) has shared an announcement.

Patrys Limited announced the cessation of James Campbell as a director, effective November 10, 2025. This change in the board of directors may influence the company’s strategic direction and stakeholder confidence, as Campbell held a significant number of shares both personally and through Barrabool Biotechnology Pty Ltd.

More about Patrys Limited

Patrys Limited operates in the biotechnology industry, focusing on the development of novel antibody therapies. The company is engaged in creating innovative treatments that target various diseases, leveraging its proprietary technologies to enhance therapeutic outcomes.

Average Trading Volume: 1,073,778

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$12.61M

Find detailed analytics on PAB stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1